|
ViroPharma Vows Further Legal Action to Block Vancocin Generics
ViroPharma plans to seek an injunction to block newly approved generics on its antibiotic Vancocin after the FDA rejected its longstanding citizen petition protesting bioequivalence standards for the product.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives